abstract |
Compounds represented by formula (1) or their pharmaceutical acceptable salts are provided. [wherein, A represents cyclic ring etc., B represents 1H-tetrazole-5-yl or 2, 4-dioxothiazolidine-5-yl, Y represents a single bond or a C6-10 arylene group.] |